Tessara Therapeutics Pty Ltd is a regenerative medicine company developing RealBrain® technology to break therapeutic barriers in the biopharmaceutical industry. RealBrain® technology is based on human mimetic 3D neural micro-tissues designed to have high physiological relevance, manufactured at industrial scale for unprecedented reproducibility. Priority applications include a high-throughput drug screening platform that includes a range of models of healthy and diseased brain tissue, and a regenerative medicine platform to develop next generation safe and efficacious tissue therapies for significant unmet neurological medical needs.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 566 St Kilda Rd, 103,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tessaratherapeutics.com
- Keywords
- Regenerative medicine, Drug screening, Neuroscience, paradigm shift, Brain, Micro-tissues, Biotechnology, 3Dmodels, Tissuetherapy.
- HQ
- Melbourne, Victoria
Tessara Therapeutics Questions
Tessara Therapeutics's website is tessaratherapeutics.com
Tessara Therapeutics's LinkedIn profile is https://au.linkedin.com/company/tessara-therapeutics
Tessara Therapeutics has
10 employees.
View email and phone details for 10
employees at Tessara Therapeutics.
Tessara Therapeutics's industry is
Biotechnology Research
Tessara Therapeutics's top competitors are
Inosi Therapeutics Pty Ltd,
Xylo Bio,
Nutromics,
Misti,
Pacalis Therapeutics Pty Ltd,
Tessera Therapeutics,
Proxima Bio,
Jumar Bioincubator,
Immunosis,
Polyactiva.
Tessara Therapeutics's categories are Biotechnology Research
Tessara Therapeutics's founding year is 2018
